fbpx Skip to main content


On the Road to Victories: Janssen Employees Cycle for Multiple Myeloma

On the Road to Victories: Janssen Employees Cycle for Multiple Myeloma

Janssen’s Rob Forbes, Director, Global Strategic Marketing, Oncology,
and Megan Farina, Communication Leader

How far would you go to put a stop to cancer?

The Janssen Oncology team goes the distance every day to help achieve victories over cancer. Recently, two members of our team took the challenge a step — or rather, thousands of pedal rotations — further, by representing Janssen and cycling 546 miles in the first eight days of the Multiple Myeloma Research Foundation (MMRF) Road to Victories cross-country bike ride.

The event, sponsored by Janssen Oncology in partnership with the MMRF, was created to raise awareness, fund research, and build patient education and community support around multiple myeloma.

According to the American Cancer Society, multiple myeloma occurs when malignant plasma cells multiply in the bone marrow, crowding out the normal plasma cells that help fight infections. These malignant myeloma cells can then cause tumors, called plasmacytomas, which can damage the kidneys, lower immune function, and cause bone problems. It’s currently incurable. This year, an estimated 30,000 Americans are expected to be diagnosed with multiple myeloma, the second most-common type of blood cancer in the United States behind lymphoma and leukemia.

The 3,400-mile Road to Victories ride, from Los Angeles, California, to Fairfield, Connecticut, kicked off on September 2, 2017. Janssen Oncology’s Megan Farina, Communication Leader, and Rob Forbes, Director, Global Strategic Marketing, Oncology, were part of an 11-rider team who tackled the first leg of the trek, spanning from Los Angeles through the Mojave Desert to Flagstaff, Arizona.

Megan Farina and Rob Forbes in California,
prior to the start of their ride.

Doing the ride was special for both Megan and Rob. “Through my work at Janssen, I’ve been inspired by the remarkable spirit of those battling multiple myeloma,” Megan said. “I rode in support of furthering research that may one day help find a cure.”

For Rob, doing the ride was even more personal. “I’m honored to have ridden for my friend who has multiple myeloma and still takes on new challenges,” Rob said. “I rode also to encourage others to overcome obstacles.”

While there have been advancements in multiple myeloma, there is still more work to be done. We strive every day to accelerate progress and we are fully committed to the multiple myeloma community. We are also thrilled to support not only the Janssen employees who participated in this ride, but also all the inspiring cyclists.

The grand finale of the ride took place on October 21, 2017. While the 3,400 mile ride is over for this year, you can still follow #roadtovictories on social media to learn more about the MMRF.



Human lung bronchioalveolar carcinoma cell